ALLE
60
7
BLK
66
12
ZTS
19
-4
EMC
69
4
UNP
49
3
AIG
42
3
AES
49
5
SCHW
59
3
M
49
3
NWL
60
2
SYK
40
3
BXP
34
3
KLAC
80
4
RIG
49
-3
HBAN
70
6
YUM
62
4
NVDA
56
4
IRM
52
3
SPG
41
-12
MLM
64
3
ALLE
60
7
BLK
66
12
ZTS
19
-4
EMC
69
4
UNP
49
3
AIG
42
3
AES
49
5
SCHW
59
3
M
49
3
NWL
60
2
SYK
40
3
BXP
34
3
KLAC
80
4
RIG
49
-3
HBAN
70
6
YUM
62
4
NVDA
56
4
IRM
52
3
SPG
41
-12
MLM
64
3
Financhill
Back

Nektar Therapeutics Stock Price Chart

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
36

NKTR
Nektar Therapeutics

Last Price:
$37.60
Seasonality Move:
-2.36%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight selling pressure.

Nektar Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 39.3 Sell
20-day SMA: 42.38 Sell
50-day SMA: 51.47 Sell
200-day SMA: 33.83 Buy
8-day EMA: 38.62 Sell
20-day EMA: 42.82 Sell
50-day EMA: 47.96 Sell
200-day EMA: 38.77 Sell

Nektar Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.34 Sell
Relative Strength Index (14 RSI): 27.99 Sell
Chaikin Money Flow: -1415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.83 - 51.03) Sell
Bollinger Bands (100): (41.55 - 61.55) Sell

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Nektar Therapeutics Stock

Is Nektar Therapeutics Stock a Buy?

NKTR Technical Analysis vs Fundamental Analysis

Sell
36
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy or a Sell?

Nektar Therapeutics Stock Info

Market Cap:
611.7M
Price in USD:
35.36
Share Volume:
578.9K

Nektar Therapeutics 52-Week Range

52-Week High:
66.92
52-Week Low:
6.48
Sell
36
Nektar Therapeutics (NKTR) is a Sell

Nektar Therapeutics Share Price Forecast

Is Nektar Therapeutics Stock a Buy?

  • Nektar Therapeutics share price is 35.36 while NKTR 8-day exponential moving average is 38.62, which is a Sell signal.
  • The stock price of NKTR is 35.36 while Nektar Therapeutics 20-day EMA is 42.82, which makes it a Sell.
  • Nektar Therapeutics 50-day exponential moving average is 47.96 while NKTR share price is 35.36, making it a Sell technically.
  • NKTR stock price is 35.36 and Nektar Therapeutics 200-day simple moving average is 38.77, creating a Sell signal.

Fundamental Analysis of Nektar Therapeutics

Is Nektar Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.

Technical Analysis of Nektar Therapeutics

Should I short Nektar Therapeutics stock?

* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.